Related references
Note: Only part of the references are listed.IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Joshua Bennett et al.
CURRENT OPINION IN HEMATOLOGY (2022)
Phase 1 study of KT-413, a targeted protein degrader, in adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Don A. Stevens et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
Gaurav S. Choudhary et al.
ELIFE (2022)
Preleukemic and leukemic evolution at the stem cell level
Jacob Stauber et al.
BLOOD (2021)
Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia
Yifeng Dai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2021)
Differentiation therapy for myeloid malignancies: beyond cytotoxicity
Ryan J. Stubbins et al.
BLOOD CANCER JOURNAL (2021)
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
Jennifer J. Trowbridge et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome
Phoebe C. R. Parrish et al.
CELL REPORTS (2021)
The Interleukin-4 Receptor-Associated Kinase Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial
Aaron Winkler et al.
ARTHRITIS & RHEUMATOLOGY (2021)
E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2
Yubin Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Toll-like Receptors and the Control of Immunity
Katherine A. Fitzgerald et al.
CELL (2020)
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor
LaQuita M. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies
Venkateshwar Rao Gummadi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
New directions for emerging therapies in acute myeloid leukemia: the next chapter
Naval Daver et al.
BLOOD CANCER JOURNAL (2020)
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
David A. Sallman et al.
BLOOD (2019)
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies
Molly A. Smith et al.
NATURE CELL BIOLOGY (2019)
Targeting IRAK4 for Degradation with PROTACs
Joao Nunes et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation
Samuel A. Stoner et al.
BLOOD (2019)
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
Katelyn Melgar et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications
Ruben A. L. de Groen et al.
HAEMATOLOGICA (2019)
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Andrei V. Krivtsov et al.
CANCER CELL (2019)
The signaling axis atypical protein kinase C λ/ι-Satb2 mediates leukemic transformation of B-cell progenitors
R. C. Nayak et al.
NATURE COMMUNICATIONS (2019)
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
Bettina Wingelhofer et al.
LEUKEMIA (2018)
Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes
Mona M. Hosseini et al.
LEUKEMIA (2018)
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
Luis A. Carvajal et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
Amandeep Aujla et al.
BIOMARKER RESEARCH (2018)
Chronic immune response dysregulation in MDS pathogenesis
Laura Barreyro et al.
BLOOD (2018)
The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation
Benjamin Mizukawa et al.
BLOOD (2017)
Polycomb repressive complexes in hematological malignancies
Atsushi Iwama
BLOOD (2017)
Stem and progenitor cell alterations in myelodysplastic syndromes
Aditi Shastri et al.
BLOOD (2017)
Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia
Kaiwei Liang et al.
CELL (2017)
The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia
G. Giotopoulos et al.
ONCOGENE (2016)
The Role of Toll-Like Receptors in Hematopoietic Malignancies
Darlene A. Monlish et al.
FRONTIERS IN IMMUNOLOGY (2016)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
Deconstructing innate immune signaling in myelodysplastic syndromes
Melinda E. Varney et al.
EXPERIMENTAL HEMATOLOGY (2015)
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
I. Ganan-Gomez et al.
LEUKEMIA (2015)
Directed evolution of APEX2 for electron microscopy and proximity labeling
Stephanie S. Lam et al.
NATURE METHODS (2015)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
Garrett W. Rhyasen et al.
CANCER CELL (2013)
Differential IRAK signaling in hematologic malignancies
Garrett W. Rhyasen et al.
EXPERIMENTAL HEMATOLOGY (2013)
Concise Review: Preleukemic Stem Cells: Molecular Biology and Clinical Implications of the Precursors to Leukemia Stem Cells
Ashley Pandolfi et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Sophie Park et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Innate Immune Signaling in the Myelodysplastic Syndromes
Daniel T. Starczynowski et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers
Ping Chi et al.
NATURE REVIEWS CANCER (2010)
Share Paper
